Oct 31, 2024 / 10:00AM GMT
Presentation
Oct 31, 2024 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Christopher O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Giles Platford
Takeda International Uk Branch - Director
=====================
Conference Call Participants
=====================
* Stephen Barker
Jefferies - Analyst
* Michael Nedelcovych
TD Cowen - Analyst
* Matsubara San
Nomura Securities Co. - Analyst
* Tony Ren
Macquarie Research - Analyst
* Miki Sogi
Bernstein - Analyst
* Editor
=====================
Christopher O'Reilly Takeda
Takeda Pharmaceutical Co Ltd
(WBO:TKD)
€
29.96
+0.050 (+0.17%)
Market Cap: 47.82 Bil
Enterprise Value: 70.72 Bil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 19/100 Q2 2025 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Oct 31, 2024 / 10:00AM GMT
Release Date Price:
€25.65
(+1.26%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot